CONTEXT: Publication of a peer reviewed study in the ASCO journal showing RWE derived mortality data and the improvements this will confer in future study design endpoints and trial patient selection.
IMPACT: low
READ TIME: 2 mins
Quality Level Mean [1 – 10]: 6
1. “SAN FRANCISCO, April 09, 2021 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today announced that the findings of a peer-reviewed study were published in JCO Clinical Cancer Informatics (JCO-CCI), an American Society of Clinical Oncology (ASCO) Journal.”
2. “The study, titled “Validation of a mortality composite score in the real-world setting: overcoming source specific disparities and biases,” explored the Syapse Learning Health Network platform’s ability to accurately assess oncology mortality rates, ultimately demonstrating that a composite mortality score was capable of achieving sensitivity of 94.9% and specificity of 92.8%, as compared to the National Death Index (NDI), with concordance within one day of 98.7%.”
3. “The Syapse Learning Health Network™ draws upon a combination of six individual real-world data sources to develop a high-quality composite mortality score.”
4. ““This is really important, given that complete and accurate mortality data is critical for development of real-world endpoints, such as overall survival, and selection of patients for clinical trials.””
5. “About the Syapse Learning Health Network™. This international network of healthcare providers enables improved cancer care by sharing real-world data to support clinical decisions and by fostering collaborations among participants.”